On Friday, Asian blockchain firms Longenesis and Neuromation announced they have formed a partnership to create a blockchain-based global data marketplace where individuals will take control of their personal data and healthcare companies may invest in AI analysis they previously could not afford.
Neuromation reported it recently raised over $70 million through a token generating event (TGE) to develop a system for generation of the synthetic data using the deep neural networks trained on a large number of examples and using the processing power of the many graphics processing units (GPUs) in the blockchain community. Speaking about the company’s progress, Maxim Prasolov, CEO of Neuromation, stated:
“Here at Neuromation, our mission is to help companies use our platform to carry out all their data analysis faster and cheaper than anywhere in the world. In our opinion all industries, including healthcare, will benefit tremendously from a flexible, blockchain-based research platform. Our partnership with Longenesis represents this huge potential.”
Founded in 2017 Longenesis describes itself as a revolutionary blockchain-based Life Data Marketplace platform which provides modular toolsets coupled with integrated advanced Artificial Intelligence (AI) systems to store, manage, and trade life data: social network data, health data, and medical records. The company explained:
“Essentially, Longenesis is a life data marketplace that aims to facilitate the sale/purchase of human data between Users (General public) and Customers (Drug development/Pharmaceutical companies). Users will be able to earn a good universal basic income by using Longenesis. It was created by two titans in the industries of Blockchain and Medical Artificial Intelligence.”
Both companies revealed that they are developing revolutionary ecosystems using blockchain technologies. Alex Zhavoronkov, PhD, CSO of Longenesis, commented:
“Our goal is to create a new, data-driven economy and we’re excited to partner with Neuromation to move one step closer to our goal. Our collaboration will be two-fold. First, we’ll train the deep neural networks we need processing power and we are looking to repurpose the cryptocurrency mining equipment to do that. Second, to generate synthetic data, we must train on large data sets of real-world data and have balanced and diverse data sets. Neuromation is an obvious consumer of data and can be a part of the marketplace.”
Prasolov added:
“The primary aim of Longenesis is to create a global data marketplace that will help provide personalized but at the same time secure data for healthcare application developers. Hence, the missions of Neuromation and Longenesis are perfectly complementary to each other. Together we will bring to AI practitioners in medicine and healthcare both the data and the computational power needed to train AI models and improve healthcare throughout the world. By announcing this partnership, we are laying the foundation for the future world of individualized healthcare based on artificial intelligence.”
